SIDP Antimicrobial Stewardship - A Certificate Program-PHASE 1&2 ONLY

Description

The Antimicrobial Stewardship Certificate Program (ASP) is an innovative and intensive practice-based activity for pharmacists focusing on the pharmacist's role in the area of appropriate use of antimicrobial agents. The certificate program, which emphasizes a health care team approach, seeks to foster the development of a strong knowledgebase in microbiology, pharmacology and disease state management in order to successfully implement an antibiotic stewardship program that will improve patient care, reduce healthcare expenditures and potentially reduce rates of resistance and prolong the longevity of the limited number of antimicrobial agents available to treat infections.

Antimicrobial Stewardship Certificate Program Goals

The program goals/learning objectives are the following:

  • Outline the essentials of clinical microbiology, pharmacology, pharmacokinetics, pharmacodynamics, and infectious disease state management necessary in Antimicrobial Stewardship.
  • Identify the skills needed to establish an antimicrobial stewardship program.
  • Implement interventions to improve patient care, minimize resistance and cost, and prolong the longevity of antimicrobials through a cap-stone project.
  • Explain how to evaluate the effectiveness of an antimicrobial stewardship program through the measurement of outcomes.
  • Define the interaction between pharmacy and infection control

Antimicrobial Stewardship Certificate Program Structure

The Antimicrobial Stewardship certificate training program is ACPE accredited and conducted in three parts:

  • Phase 1: Self-study learning component (28 hours or 2.8 CEUs). 
  • Phase 2: Live webinars (6-9 hours or 0.6-0.9 CEUs)

A Certificate of Achievement will be awarded to participants who successfully complete all three program components. Participants who successfully complete the program will be eligible for a 1 year free associate membership in SIDP.

The self-study and webinars must be completed within 8 months and the final project completed within 12 months of registration. To sign up and access the program, use the Pay with a Credit Card or Pay with a Check links listed at the top of the page.

Cost

Phases 1 and 2 are available for $688 per pharmacist. 

For complete details on the program, please see our downloadable Announcement.

CE Accreditation

Initial Release Date: 1-15-2021
Expiration Date: 1-15-2024
Practice Activity Number: 0221-9999-21-001-B01-P

Pharmacists

This CE activity is jointly provided by ProCE, LLC and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Practice Activity Number 0221-9999-21-001-B01-P has been assigned to this practice-based CE activity. This CE activity is approved for 44.0 contact hours (0.44 CEUs) in states that recognize ACPE providers. The participant can elect to complete three additional webinars at no additional cost and earn 48.5 contact hours (4.85 CEUs). Statements of completion will be issued online as individual modules are completed with a post-test score of 80% or higher and completion of an online evaluation. UANs for the individual activity modules are listed in the Activity Announcement.

Funding

No commercial funding. This activity is self-funded by SIDP and registration fees.

System Requirements:

PC:

  • Microsoft Windows 7 or above
  • Chrome (recommended), Internet Explorer (v9 or greater) or Firefox
  • Adobe Acrobat Reader
  • Sound Card and Speakers
  • 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
  • Flash Player Plug-in, Current Version (click here for Flash Player tips)
  • JavaScript, Java 1.6 or higher

Mac:

  • Mac OS X
  • Chrome or Firefox
  • Adobe Acrobat Reader
  • Sound Card and Speakers
  • Flash Player Plug-in, Current Version
  • JavaScript

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.